Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Construction in Progress: 2017-2018

  • Abeona Therapeutics' Construction in Progress fell 10.11% to $409,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $409,000, marking a year-over-year decrease of 10.11%. This contributed to the annual value of $409,000 for FY2018, which is 10.11% down from last year.
  • According to the latest figures from Q4 2018, Abeona Therapeutics' Construction in Progress is $409,000, which was down 10.11% from $455,000 recorded in Q4 2017.
  • Abeona Therapeutics' 5-year Construction in Progress high stood at $455,000 for Q4 2017, and its period low was $409,000 during Q4 2018.
  • For the 2-year period, Abeona Therapeutics' Construction in Progress averaged around $432,000, with its median value being $432,000 (2017).
  • Data for Abeona Therapeutics' Construction in Progress shows a maximum YoY decreased of 10.11% (in 2018) over the last 5 years.
  • Abeona Therapeutics' Construction in Progress (Quarterly) stood at $455,000 in 2017, then declined by 10.11% to $409,000 in 2018.